novo nordisk ozempic - Search News

News

Hims, Novo Nordisk and Drugs

Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent mandate. Hims pushed back against the accusation.

CBS News on MSN · 1d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Bloomberg on MSN · 1d

Novo Exits Hims Partnership, Citing Concerns Over Compounded Drugs

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is using “deceptive marketing” to sell copycat versions of its obesity blockbuster Wegovy.

Novo Nordisk, Hers Stock

Barron's on MSN · 1d

Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.

Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled as the results missed investors’ expectations and reignited concerns about Novo’s rivalry with Eli Lilly.

Medical Dialogues · 4h

Weight loss drug: Novo Nordisk Wegovy now available in India

Mumbai: Novo Nordisk, a global healthcare company headquartered in Denmark, has announced the launch of Wegovy (injectable Semaglutide) - a once-weekly glucagon-like peptide-1 receptor

The Wall Street Journal on MSN · 1d

Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup

The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations about Hims’ compounding and deceptive marketing practices.

1don MSN

EU drugs regulator to allow Novo Nordisk to include heart condition in Ozempic label

Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...

New Atlas2d

Ozempic maker announces not one, but three new weight-loss drugs

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...

Investing.com South Africa2h

Novo Nordisk stock falls after Spain probes obesity awareness campaign

Novo Nordisk A/S (NYSE:NVO) stock dropped 2.1% premarket following news that Spain’s health ministry has requested clarification about the company’s obesity awareness campaign, which may have violated ...

1don MSN

Novo Nordisk Stock Sinks as Latest Weight-Loss Drug Trial Disappoints

Novo Nordisk's U.S.-listed shares fell close to 6% Monday after the drugmaker revealed the latest results for a new ...

Pharmabiz5h

CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease

CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...

CNBCTV188h

Novo Nordisk launches blockbuster weight loss drug Wegovy in India

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...

24/7 Wall St.5d

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

12hon MSN

Novo Nordisk’s Wegovy debuts in India: How it works, who it’s for, and how much it costs

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

5don MSN

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results